EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Human leukocyte antigen genotype modulates cytomegalovirus- and Epstein–Barr virus-specific T-cell response in healthy donors for optimized virus-specific T-cell donor selection

Rut Mora-Buch, Helena Pasamar, Maria Tomás-Marín, Emma Enrich, María Andrés-Rozas, Cleofé Peña-Gómez, Miriam García Bosca, Francesc Rudilla

Frontiers in Immunology · 14.08.2026 · 17

DOI: 10.3389/fimmu.2026.1856550 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Immunology, online erschienen am 14.08.2026. Verfasst von Rut Mora-Buch und 7 weiteren Autor:innen. Beteiligte Einrichtung: Advanced & Cell Therapy Services, Blood and Tissue Bank (BST), Barcelona, Spain. Hauptthemen laut MEDLINE: Herpesvirus 4, Human, Cytomegalovirus, HLA Antigens, Epstein-Barr Virus Infections. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Reactivation of cytomegalovirus (CMV) and Epstein–Barr virus (EBV) is a major complication in immunocompromised patients, and understanding donor variability in antiviral immunity is essential for optimizing adoptive T-cell therapy. This study aimed to identify immunogenetic determinants of virus-specific T-cell responses in healthy donors to guide donor selection.

Methods

CMV- and EBV-specific T-cell responses were characterized using flow cytometry and IFN-g ELISpot after stimulation with peptide pools, followed by integrated analyses correlating the response magnitude with human leukocyte antigen (HLA) class I and II alleles, HLA haplotypes, and HLA-G 3′UTR polymorphisms.

Results

CMV 65-kDa phosphoprotein (pp65) induced stronger CD8 + and CD4 + T-cell responses than immediate early 1 (IE1), whereas the EBV consensus peptides preferentially activated CD8 + T cells. Several HLA alleles and linked haplotypic backgrounds were associated with enhanced or reduced CMV-specific T-cell responses, including an A*01:01~C*07:01~B*08:01~DRB1*03:01~DQB1*02:01 haplotype enriched among low responders. For EBV, several HLA-restricted alleles were associated with stronger peptide-specific activation, supporting the broad immunogenicity of the consensus peptide pool. Moreover, HLA-G 3′UTR polymorphisms selectively modulated the CMV-specific IFN-γ + CD8 + T-cell frequencies.

Discussion

Together, these results indicate that classical and non-classical HLA variations are associated with inter-donor differences in antiviral T-cell response in an antigen- and virus-dependent manner, providing a translational framework to refine donor selection and improve the design of T-cell-based immunotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 4, HumanCytomegalovirusHLA AntigensEpstein-Barr Virus InfectionsCytomegalovirus InfectionsCD8-Positive T-LymphocytesDonor SelectionT-LymphocytesCD4-Positive T-LymphocytesHumansGenotypePhosphoproteinsViral Matrix ProteinsLymphocyte Activation

Stichwörter der Autor:innen

CMVEBVHLAallogenic immunotherapyvirus-specific T cells

Substanzen

HLA AntigensPhosphoproteinsViral Matrix Proteins

Autor:innen und Institutionen

  • Advanced & Cell Therapy Services, Blood and Tissue Bank (BST), Barcelona, Spain.
  • Transfusional Medicine Group, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona (VHIR-UAB), Barcelona, Spain.
  • Immunogenetics and Histocompatibility Laboratory, Blood and Tissue Bank (BST), Barcelona, Spain.
  • Barcelona Supercomputing Center, Barcelona, Spain.

Zitieren

APA

Mora-Buch, R., Pasamar, H., Tomás-Marín, M., Enrich, E., Andrés-Rozas, M., Peña-Gómez, C., García Bosca, M., & Rudilla, F. (2026). Human leukocyte antigen genotype modulates cytomegalovirus- and Epstein–Barr virus-specific T-cell response in healthy donors for optimized virus-specific T-cell donor selection. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.1856550

Vancouver

Mora-Buch R, Pasamar H, Tomás-Marín M, Enrich E, Andrés-Rozas M, Peña-Gómez C, et al. Human leukocyte antigen genotype modulates cytomegalovirus- and Epstein–Barr virus-specific T-cell response in healthy donors for optimized virus-specific T-cell donor selection. Frontiers in Immunology. 2026;17. doi:10.3389/fimmu.2026.1856550

BibTeX
@article{MoraBuch2026,
  author = {Mora-Buch, Rut and Pasamar, Helena and Tomás-Marín, Maria and Enrich, Emma and Andrés-Rozas, María and Peña-Gómez, Cleofé and García Bosca, Miriam and Rudilla, Francesc},
  title = {Human leukocyte antigen genotype modulates cytomegalovirus- and Epstein–Barr virus-specific T-cell response in healthy donors for optimized virus-specific T-cell donor selection},
  journal = {Frontiers in Immunology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fimmu.2026.1856550}
}
Kostenlos starten →